Contract Research Services

Your one contract research source for pharmaceutical, medical device, in vitro diagnostic, crop protection and chemical testing.

Contact Us

Explore contract research development services by industry, phase, disease indication, molecule type, location or compliance. 

Pharmaceutical Drug Development

Nonclinical & clinical

Device & Diagnostic Development

Nonclinical & clinical

Product Development & Testing

Crop protection & chemical

Global, adaptive & scalable contract research services

Whether you need a complete preclinical to commercialization program, a multi-site/multi-national program of clinical studies or a small regional study, get the scalability you require - backed by global expertise, regulatory guidance and informatics systems that provide you with better insights, faster.

A Global Contract Research Organization

We may have nearly 70,000 employees worldwide, but the people we think of most are the patients who benefit directly from the drugs we help develop. 

With the support of our diagnostics capabilities and a commitment to deliver clinical trials that are both reliable and rigorous, we're able to support clinical trial research efforts in nearly 100 countries. 

And that's one of the reasons why fifty of the top drugs developed in 2019 were supported by our clinical data and contract research services. 

Enabling Clear Decisions

With more than 50 years of experience in the contract research industry, we are passionate about harnessing science to advance health. 

Each of our studies, assays and clinical trials are designed to get you information as quickly and efficiently as possible, so you can make go/no-go decisions quickly. 

Don't go it alone. Choose a partner, focused on getting your timely information to inform decision-making through every stage of the product lifecycle continuum. 

Development by Therapeutic Indication

From in vivo pharmacology disease models to late-stage clinical trials, we have experience bringing treatment therapies for a variety of diseases to market. 


The COVID-19 outbreak that began in Wuhan, China, in December 2019 was declared a pandemic on 
March 11, 2020 by the World Health Organization, and has since affected almost every country around the world. Cancer patients have been significantly impacted, through both clinical practice as well as engagement and participation in clinical research. This has had a significant impact on cancer care for patients and drug development timelines for sponsors; and as a result contract research organizations (CROs) had to quickly pivot and adapt their strategies to ensure patients stayed safe from COVID 19, while continuing to participate in trials. Since this pandemic is anticipated to continue for an unknown period of time, we need to carefully evaluate the lessons learned so far in the COVID-19 era, and determine how to leverage these experiences to positively impact oncology drug development in the future.

Development by Scientific Discipline

Our labs and scientists complete thousands of assays, studies and tests every day. From toxicology and bioanalysis to genomics and biomarker detection, we have the contract research capacity and resources to handle your testing needs. 

Sign up

Let's start a conversation

Contact Us